T1	Pharmacological_substance 33 43	fluoxetine
N1000 	Reference T1 MeSH:D005473	fluoxetine
T2	Pharmacological_substance 47 56	cisapride
N1001 	Reference T2 MeSH:D020117	cisapride
T3	Pharmacological_substance 141 151	fluoxetine
N1002 	Reference T3 MeSH:D005473	fluoxetine
T4	Pharmacological_substance 205 214	cisapride
N1003 	Reference T4 MeSH:D020117	cisapride
T5	Pharmacological_substance 440 449	cisapride
N1004 	Reference T5 MeSH:D020117	cisapride
T7	Pharmacological_substance 512 522	fluoxetine
N1005 	Reference T7 MeSH:D005473	fluoxetine
T9	Pharmacological_substance 560 569	cisapride
N1006 	Reference T9 MeSH:D020117	cisapride
T11	Pharmacological_substance 606 616	fluoxetine
N1007 	Reference T11 MeSH:D005473	fluoxetine
T13	Pharmacological_substance 763 772	cisapride
N1008 	Reference T13 MeSH:D020117	cisapride
T16	Pharmacological_substance 1008 1018	fluoxetine
N1009 	Reference T16 MeSH:D005473	fluoxetine
T17	Pharmacological_substance 1043 1052	cisapride
N1010 	Reference T17 MeSH:D020117	cisapride
T18	Pharmacological_substance 1172 1181	cisapride
N1011 	Reference T18 MeSH:D020117	cisapride
T19	Pharmacological_substance 1196 1206	fluoxetine
N1012 	Reference T19 MeSH:D005473	fluoxetine
T20	Pharmacological_substance 1208 1217	Cisapride
N1013 	Reference T20 MeSH:D020117	Cisapride
T21	Pharmacological_substance 1269 1279	fluoxetine
N1014 	Reference T21 MeSH:D005473	fluoxetine
T22	Pharmacological_substance 1281 1290	Cisapride
N1015 	Reference T22 MeSH:D020117	Cisapride
T23	Pharmacological_substance 1367 1377	fluoxetine
N1016 	Reference T23 MeSH:D005473	fluoxetine
T24	Subject 95 113	healthy volunteers
T14	Subject 234 245	healthy men
T29	Subject 316 346	Twelve healthy male volunteers
T39	Combination 1191 1195	with
T41	Combination 1330 1339	receiving
T45	Coreferring_mention 348 360	Each subject
T46	Combination 601 605	plus
T48	Combination 1264 1268	with
T6	Combination 988 1004	Coadministration
